SCHEMBL5491677

SCHEMBL5491677

COc1cccc(N(c2ccc(/C=C/c3ccccc3)cc2)c2cccc(OC)c2)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RELA Q04206 4/20 0.58
TRPA1 O75762 1/20 0.56
NFE2L2 Q16236 5/20 0.54
CYP19A1 P11511 1/20 0.54
CYP1A1 P04798 2/20 0.51
CYP1A2 P05177 2/20 0.51
CYP1B1 Q16678 2/20 0.51
NQO2 P16083 1/20 0.50
MAOB P27338 1/20 0.48
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
USP2 O75604 1/20 0.47
ALDH1A1 P00352 1/20 0.47
TP53 P04637 1/20 0.47
CYP3A4 P08684 1/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
KMT2A Q03164 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
TRPV1 Q8NER1 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5491678 1.00 RELA (0.58) RELATRPA1NFE2L2CYP19A1CYP1A1
SCHEMBL8943695 0.98 RELA (0.56) RELATRPA1NFE2L2CYP19A1CYP1A1
SCHEMBL8943692 0.98 RELA (0.56) RELATRPA1NFE2L2CYP19A1CYP1A1
SCHEMBL21738398 0.95 RELA (0.59) RELATRPA1NFE2L2CYP19A1CYP1A1
SCHEMBL7901537 0.94 RELA (0.53) RELATRPA1NFE2L2CYP19A1CYP1A1
SCHEMBL7901534 0.94 RELA (0.53) RELATRPA1NFE2L2CYP19A1CYP1A1
SCHEMBL16274498 0.94 RELA (0.51) RELATRPA1NFE2L2CYP19A1CYP1A1
SCHEMBL260888 0.94 RELA (0.68) RELATRPA1NFE2L2CYP19A1CYP1A1
SCHEMBL5492461 0.94 RELA (0.68) RELANFE2L2CYP19A1CYP1A1CYP1A2
SCHEMBL5487613 0.94 RELA (0.68) RELANFE2L2CYP19A1CYP1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7276627-B2 One pot sequential reactions and novel products produced thereby IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2007-10-02 US claimed
US-20060224017-A1 One pot sequential reactions and novel products produced thereby IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2006-10-05 US claimed
US-7276627-B2 One pot sequential reactions and novel products produced thereby IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2007-10-02 US disclosed
US-20060224017-A1 One pot sequential reactions and novel products produced thereby IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2006-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060224017-A1 One pot sequential reactions and novel products produced thereby PNMT, CYP1A1, TERT RELA 1503/4885TRPA1 1677/4885NFE2L2 446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.